Molecule shown to produce cognitive improvement in rodents with early Alzheimer's disease
A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...
来自MSN1 小时
Zunveyl: An Improved Alzheimer's Drug With Fewer Side Effects Will Be Available Soon
Fact checked by Nick Blackmer Zunveyl (benzgalantamine)—a better-tolerated version of the Alzheimer’s drug Razadyne ...
The risk of dementia is even worse than we thought, new research says
The findings highlight the need for public-health strategies aimed at mitigating dementia risk and promoting healthy aging across diverse populations, researchers said. “I think ...
Dementia Cases in the U.S. Expected to Double by 2060, Hitting 1 Million a Year
Cases of dementia in the U.S. are expected to steadily rise in the coming years, hitting 1 million annual cases by 2060.
Daijiworld17 小时
Costly therapies to foster Alzheimer’s market growth globally: Report
New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according to a report. The report by GlobalData, a data and analytics company, showed ...
New study shows risk of developing dementia in the U.S. is much higher than previously ...
People in the United States are living longer and with that comes increased rates of dementia. Dr. Josef Coresh, with NYU ...